Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer

Published 2019 View Full Article

Authors

Keywords

Immunotherapy, Immune checkpoint inhibitors, Chemotherapy, Lung cancer, Immunogenic cell death, Tumor immune microenvironment, Optimal patient selection

Journal

DRUG RESISTANCE UPDATES

Volume 46, Issue -, Pages 100644

Publisher

Elsevier BV

Online

2019-09-18

DOI

10.1016/j.drup.2019.100644

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started